DEA Accepts New Report in Rescheduling Hearing; Foes Seek Discovery

DEA Raises No Objection to the New Report

DEA said it's fine with including a new report in the marijuana rescheduling hearing record, according to Marijuana Moment's reporting on Tuesday.

The agency's position matters because an agency that opposes new evidence can slow a proceeding. One that accepts it keeps the schedule moving. The report's author and contents weren't available in the source material CannIntel reviewed, so we aren't characterizing them.

Opponents Ask to Widen the Record

Opponents of rescheduling are seeking new testimony and document discovery. Those are two separate asks. Both would extend the evidentiary phase.

New testimony puts more witnesses before the presiding officer. Discovery gives parties a way to demand documents from the government. Neither is a minor request in an administrative hearing built around a defined record.

Two Positions, One Procedural Fight

DEA's acceptance of the report and the opponents' discovery push are separate moves that pull the hearing in different directions. One folds new material into the existing record. The other would reopen how that record gets built.

DEA's willingness to admit the report while opponents ask to expand the record turns the dispute into a fight over scope, not just substance.

That's a procedural read, not a prediction. How the presiding officer rules on each request will decide it.

Why Operators Are Watching the Calendar

Every procedural delay pushes back the date licensed operators could stop paying under Section 280E of the tax code. Schedule III placement would remove marijuana businesses from that provision's reach, which is why the timeline carries real dollars for MSOs and single-store owners alike.

Discovery rarely moves quickly. Neither does a reopened witness list.

What the Source Material Doesn't Say

The signal doesn't identify the report, the filing parties, the hearing date or any ruling. It also doesn't say whether HHS or FDA materials are involved.

CannIntel won't guess at those details. Docket filings, once reviewed, will fill them in. For full background on this story, see the CannIntel topic hub on DEA marijuana rescheduling.

The Next Signal

The next marker is a ruling on whether the opponents' testimony and discovery requests go forward. Watch the docket for a scheduling order, since a grant of discovery would likely add weeks or months before any final rule on Schedule III reaches the Federal Register.